Thus, in addition to the five SCLC-Y lines directly examined in this study, these findings suggest that an additional two previously designated SCLC-Y lines (H1339/H157DM and H2286) are SMARCA4-mutant NSCLC rather than SCLC. Here, SMARCA4 is linked to small cell lung carcinoma.